Regression From Early GDM to Normal Glucose Tolerance and Adverse Pregnancy Outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
29 Mar 2024
29 Mar 2024
Historique:
received:
18
11
2023
accepted:
19
02
2024
medline:
29
3
2024
pubmed:
29
3
2024
entrez:
29
3
2024
Statut:
aheadofprint
Résumé
To compare pregnancy outcomes among women with a normal oral glucose tolerance test (OGTT) before 20 weeks' gestation (early) and at 24-28 weeks' gestation (late) (no gestational diabetes mellitus, or No-GDM), those with early GDM randomized to observation with a subsequent normal OGTT (GDM-Regression), and those with GDM on both occasions (GDM-Maintained). Women at <20 weeks' gestation with GDM risk factors who were recruited for a randomized controlled early GDM treatment trial were included. Women with treated early GDM and late GDM (according to the World Health Organization's 2013 criteria) were excluded from this analysis. Logistic regression compared pregnancy outcomes. GDM-Regression (n = 121) group risk factor profiles and OGTT results generally fell between the No-GDM (n = 2,218) and GDM-Maintained (n = 254) groups, with adjusted incidences of pregnancy complications similar between the GDM-Regression and No-GDM groups. Women with early GDM but normal OGTT at 24-28 weeks' gestation had pregnancy outcomes that were similar to those of individuals without GDM. Identifying early GDM likely to regress would allow treatment to be avoided.
Identifiants
pubmed: 38551955
pii: 154408
doi: 10.2337/dc23-2215
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Western Sydney University
ID : 2019
Organisme : Medical Scientific Fund of the Mayor of Vienna
ID : 15205
Organisme : Region Örebro Research Committee
ID : 15205
Organisme : South Western Sydney Local Health District Academic Unit Grant
ID : 2016
Organisme : National Health and Medical Research Council
ID : 1104231
Investigateurs
David Simmons
(D)
N Wah Cheung
(NW)
Jincy Immanuel
(J)
William M Hague
(WM)
Helena Teede
(H)
Christopher J Nolan
(CJ)
Michael J Peek
(MJ)
Jeff R Flack
(JR)
Mark McLean
(M)
Vincent Wong
(V)
Emily Hibbert
(E)
Emily Gianatti
(E)
Arianne Sweeting
(A)
Suzette Coat
(S)
Raiyomand Dalal
(R)
Georgia Soldatos
(G)
Suja Padmanabhan
(S)
Rohit Rajagopal
(R)
Victoria Rudland
(V)
Jürgen Harreiter
(J)
Alexandra Kautzky-Willer
(A)
Herbert Kiss
(H)
Helena Backman
(H)
Erik Schwarcz
(E)
Glynis Ross
(G)
Viswanathan Mohan
(V)
Ranjit Mohan Anjana
(R)
Uma Ram
(U)
Informations de copyright
© 2024 by the American Diabetes Association.